Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?

被引：0
|
作者：
Takayoshi Uematsu
Masako Kasami
Junichiro Watanabe
Kaoru Takahashi
Seiji Yamasaki
Kumiko Tanaka
Yukiko Tadokoro
Akiko Ogiya
机构：
[1] Shizuoka Cancer Center Hospital,Breast Imaging and Breast Intervention Section
[2] Shizuoka Cancer Center Hospital,Department of Pathology
[3] Shizuoka Cancer Center Hospital,Division of Medical Oncology
[4] Shizuoka Cancer Center Hospital,Division of Breast Surgery
[5] Shizuoka Cancer Center Hospital,Division of Multidisciplinary Therapy for Breast Cancer
来源：
Breast Cancer | 2011年 / 18卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; Lymphovascular invasion; Pathologic complete response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：309 / 313
页数：4
相关论文
共 50 条
  • [31] Residual pure lymphovascular invasion after neoadjuvant chemotherapy - a single Institution experience
    Jang, Y.
    Cho, E. Y.
    Cho, S. Y.
    VIRCHOWS ARCHIV, 2019, 475 : S70 - S70
  • [32] Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer
    Khwaja, Shariq S.
    Ivanovich, Jennifer
    DeWees, Todd A.
    Ochoa, Laura
    Mullen, Daniel F.
    Thomas, Maria
    Margenthaler, Julie A.
    Cyr, Amy
    Naughton, Michael
    Sanati, Souzan
    Eberlein, Timothy J.
    Gillanders, William E.
    Aft, Rebecca L.
    Zoberi, Jacqueline E.
    Zoberi, Imran
    CANCER MEDICINE, 2016, 5 (02): : 230 - 238
  • [33] ANALYSIS OF COMPARATIVE EFFICACY OF NEOADJUVANT CHEMOTHERAPY REGIMENS IN BREAST CANCER
    Aggarwal, A.
    Kouzminova, N.
    Rathi, P.
    BREAST, 2013, 22 : S98 - S98
  • [34] Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer
    Seber, Erdogan Selcuk
    Iriagac, Yakup
    Cavdar, Eyyup
    Karaboyun, Kubilay
    Avci, Okan
    Yolcu, Ahmet
    Gurdal, Sibel Ozkan
    Oznur, Meltem
    Ekinci, Ferhat
    Aytac, Ali
    Gulturk, Ilkay
    Yilmaz, Mesut
    Sever, Nadiye
    Kapagan, Tanju
    Ferhatoglu, Ferhat
    Kahvecioglu, Fatma Akdag
    Hacibekiroglu, Ilhan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (01): : 37 - 41
  • [35] Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
    Kong, Xianshu
    Zhang, Qian
    Wu, Xuemei
    Zou, Tianning
    Duan, Jiajun
    Song, Shujie
    Nie, Jianyun
    Tao, Chu
    Tang, Mi
    Wang, Maohua
    Zou, Jieya
    Xie, Yu
    Li, Zhenhui
    Li, Zhen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Efficacy of neoadjuvant chemotherapy in breast cancer: arterial infusion chemotherapy vs intravenous chemotherapy
    Du, Duanming
    Jiang, Leichang
    Qiu, Shuibo
    Zhou, Ruming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 14240 - 14246
  • [37] Is lymphovascular invasion an important prognostic factor in patients with bladder cancer?
    Yossepowitch, O
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (04): : 188 - 189
  • [38] Is lymphovascular invasion an important prognostic factor in patients with bladder cancer?
    Ofer Yossepowitch
    Bernard H Bochner
    Nature Clinical Practice Urology, 2006, 3 : 188 - 189
  • [39] Can MRI predict the response to neoadjuvant chemotherapy in breast cancer accurately?
    Fatayer, H.
    Kim, B.
    Daii, B.
    Sharma, N.
    Manuel, D.
    Shabaan, A.
    Perren, T.
    Velikova, G.
    Horgan, K.
    Lansdown, M.
    CANCER RESEARCH, 2012, 72
  • [40] Correlation of lymphovascular invasion with clinicopathological factors in invasive breast cancer: a meta-analysis
    Shen, San-Di
    Zhong, Shi-Zhen
    Wang, Chun-Zhong
    Huang, Wen-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 17789 - 17795
12345